PACB - What's Going On With Pacific Biosciences Stock? | Benzinga
Pacific Biosciences of California, Inc. (NASDAQ:PACB) shares are trading lower Thursday, and the stock is down more than 20% over the past five days. Here’s a look at what’s going on.
What To Know:
On Monday, Pacific Biosciences announced preliminary unaudited revenue for the fourth quarter of $58.4 million and full year 2023 revenue of $200.5 million, representing year-over-year growth of 113% ...